Market Tracker

07/28 10:23am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

14.89
Real-Time Quote
 -0.26 / -1.72%
Today’s Change
8.29
Today|||52-Week Range
17.46
+14.98%
Year-to-Date

Today’s Trading

Previous close15.15
Today’s open15.10
Day’s range14.91 - 15.25
Volume169,073
Average volume (3 months)1,649,339
Market cap$1.4B
Dividend yield--
Data as of 10:08am ET, 07/28/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-21.38%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book27.58

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics-0.10-0.91%
DYAXDyax Corp-0.45-5.04%
ARIAARIAD Pharmaceutical...-0.25-4.33%
ABCOAdvisory Board Co-0.23-0.44%
Data as of 10:23am ET, 07/28/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts